Aprepitant
- CAS No.
- 170729-80-3
- Chemical Name:
- Aprepitant
- Synonyms
- 3-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-1H-1,2,4-triazol-5(4H)-one;Emend;Aprepitan;5-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one;CS-274;MK-0869;ONO 7436;aprepitant;Aprepirant;Fushapitan
- CBNumber:
- CB7500857
- Molecular Formula:
- C23H21F7N4O3
- Molecular Weight:
- 534.43
- MOL File:
- 170729-80-3.mol
- Modify Date:
- 2024/10/31 18:15:48
Melting point | 244-246°C |
---|---|
alpha | D25 +69° (c = 1.00 in methanol) |
Density | 1.51±0.1 g/cm3(Predicted) |
storage temp. | Sealed in dry,2-8°C |
solubility | Soluble in DMSO (>25 mg/ml) |
pka | 8.06±0.20(Predicted) |
form | powder |
color | white to beige |
optical activity | [α]/D +61 to +71°, c = 1.0 in methanol |
Stability | Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months. |
CAS DataBase Reference | 170729-80-3(CAS DataBase Reference) |
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS07,GHS08 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Signal word | Warning | |||||||||
Hazard statements | H319-H351 | |||||||||
Precautionary statements | P501-P202-P201-P264-P280-P308+P313-P337+P313-P305+P351+P338-P405 | |||||||||
HS Code | 2934990002 | |||||||||
NFPA 704 |
|
Aprepitant price More Price(4)
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Sigma-Aldrich(India) | SML2215 | Aprepitant ≥98% (HPLC) | 170729-80-3 | 5MG | ₹9331.15 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | SML2215 | Aprepitant ≥98% (HPLC) | 170729-80-3 | 25MG | ₹20112.85 | 2022-06-14 | Buy |
TCI Chemicals (India) | A3135 | Aprepitant | 170729-80-3 | 100MG | ₹8000 | 2022-05-26 | Buy |
TCI Chemicals (India) | A3135 | Aprepitant | 170729-80-3 | 500MG | ₹15000 | 2022-05-26 | Buy |
Aprepitant Chemical Properties,Uses,Production
Description
Aprepitant is an antiemetic chemical compound that belongs to “substance P” antagonists (SPA) with its effect being blocking the neurokinin 1(Nk1) receptor. It is used for the prevention of acute and delayedchemotherapy-induced nausea and vomiting(CINV) and for prevention ofpostoperative nausea and vomiting. It can also be used for the treatment of cyclic vomiting syndrome and late-stage chemotherapy induced vomiting occurring during cancer treatment. Aprepitant alleviates the case of vomiting in patients through balking the signals released by Nk1 receptors. Nk1 is a G-protein-coupled receptor with its ligand being substance P (SP). The high concentration of SP is required for the vomiting reflex. Aprepitant blocks the process of SP-NK1 signaling in activating the vomiting reflex.
Chemical Properties
Off-White to Light Yellow Cyrstalline Solid
Uses
A novel selective neurokinin-1 (NK-1) receptor antagonist. In vitro studies using human liver microsomes indicate that Aprepitant is metabolised primarily by CYP3A4 with minor metabolism by CYP1A2 and CYP2C19, and no metabolism by CYP2D6, CYP2C9, or CYP2E1. Antiemetic.
Definition
ChEBI: A morpholine-based antiemetic, which is or the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy. Aprepitant is a selective high-affinity antagonist of human substance P/ eurokinin 1 (NK1) receptors.
References
Curran, Monique P., and D. M. Robinson. "Aprepitant."Drugs69.13(2009):1853-1878.
Sant P. Chawla M.D. † ‡, et al. "Establishing the dose of the oral NK 1, antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting." Cancer 97.9(2003):2290-2300.
Warr, D. G., et al. "Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy." Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology23.12(2005):2822-30.
https://en.wikipedia.org/wiki/Aprepitant
Aprepitant Preparation Products And Raw materials
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
ANWITA APIS | +919000311012 | Hyderabad, India | 195 | 58 | Inquiry |
Varanous Labs Pvt Ltd | +91-7036248882 +91-7036248882 | Hyderabad, India | 1537 | 58 | Inquiry |
USV Pvt Ltd | +91-2267861111 +91-2225564048 | Maharashtra, India | 36 | 58 | Inquiry |
Piramal Pharma Solutions | +919892735994 | Maharashtra, India | 48 | 58 | Inquiry |
Glenmark Pharmaceuticals Limited | +912240189999 | Maharashtra, India | 93 | 58 | Inquiry |
Hetero Drugs Limited | +91-4023704923 +91-4023704923 | Telangana, India | 296 | 58 | Inquiry |
Everest Organics Limited | +91-4040028838 +91-9440409996 | Hyderabad, India | 61 | 58 | Inquiry |
Nosch Labs Pvt Ltd | +91-4048557474 +91-9948222287 | Hyderabad, India | 58 | 58 | Inquiry |
Mehta API Pvt. Ltd. | +91-9920552082 +91-9920552082 | Maharashtra, India | 33 | 58 | Inquiry |
Solara Active Pharma Sciences Ltd | +91-8046632100 +91-7075706520 | Bangalore, India | 65 | 58 | Inquiry |
Supplier | Advantage |
---|---|
ANWITA APIS | 58 |
Varanous Labs Pvt Ltd | 58 |
USV Pvt Ltd | 58 |
Piramal Pharma Solutions | 58 |
Glenmark Pharmaceuticals Limited | 58 |
Hetero Drugs Limited | 58 |
Everest Organics Limited | 58 |
Nosch Labs Pvt Ltd | 58 |
Mehta API Pvt. Ltd. | 58 |
Solara Active Pharma Sciences Ltd | 58 |
170729-80-3(Aprepitant)Related Search:
1of4
chevron_right